Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.
These evidence-based guidelines have been produced after a literature review of the treatment and prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA) infection. The guidelines were further informed by antibiotic susceptibility data on MRSA from the UK. Recommendations are given for the treatment of common infections caused by MRSA, elimination of MRSA from carriage sites and prophylaxis of surgical site infection. There are several antibiotics currently available that are suitable for use in the management of this problem and potentially useful new agents are continuing to emerge.
Gemmell
Curtis G
CG
Department of Bacteriology, Royal Infirmary, Glasgow, Scotland, UK.
Edwards
David I
DI
Fraise
Adam P
AP
Gould
F Kate
FK
Ridgway
Geoff L
GL
Warren
Rod E
RE
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D016106:Methicillin Resistance; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects*; D006113:United Kingdom
D000900:Anti-Bacterial Agents